Dr. Thomas Cech

Dr. Tom Cech Inducted into the 2024 Boulder County Business Hall of Fame

Aug. 19, 2024

Dr. Tom Cech Inducted into the 2024 Boulder County Business Hall of Fame Encouraging and Recognizing Business Excellence : The Boulder County Business Hall of Fame is a private, nonprofit 501C3 dedicated to the encouragement of business excellence in Boulder County by recognizing and inducting Boulder County business leaders into...

Nobel Laureate and University of Colorado, Boulder researcher Thomas R. Cech. Glenn J. Asakawa/University of Colorado

Here’s what a Nobel Prize-winning scientist wants you to know about the Covid-19 vaccines and the future of RNA

June 6, 2024

Dr. Thomas Cech, Nobel Laureate, in an interview with CNN, provides insight into how RNA has impacted modern medicine and biology and how mRNA, holds promise for future vaccines and other scientific and health-related breakthroughs. For many years, Cech has researched RNA and taught chemistry to undergrads at the University...

Portrait of Tom Cech

Tom Cech: How CU tackled COVID-19 testing

June 14, 2021

By Tom Cech I’ve been immersed in the new book by Walter Isaacson, modestly titled “The Code Breaker: Jennifer Doudna, Gene Editing, and the Future of the Human Race.” Multiple pages describe Jennifer’s leadership in launching COVID-19 testing on the Berkeley campus. There’s no question that Jennifer’s scientific acumen, compassion,...

cell

How does a stem cell know what to become? Study shows RNA plays key role

July 7, 2020

In a study published July 6 CU Boulder researchers come one step closer to answering that fundamental question, concluding that the molecular messenger RNA (ribonucleic acid) plays an indispensable role in cell differentiation, serving as a bridge between our genes and the so-called “epigenetic” machinery that turns them on and off.

Telomeres

The unexpected complexities of TERT, a key cancer driver

Sept. 11, 2019

Telomerase reverse transcriptase (TERT), an enzyme associated with nearly all malignant human cancers, is even more diverse and unconventional than previously realized according to new research by CU Biochem and BioFrontiers' Distinguished Professor Thomas Cech and Professor John Rinn.

double helix graphic

A key ‘kill switch’ in a gene-regulating protein group

Sept. 9, 2019

CU Boulder and Howard Hughes Medical Institute (HHMI) biochemists have revealed a key regulatory process in a gene-suppressing protein group that could hold future applications for drug discovery and clinical treatment of diseases, including cancer.

Thomas Cech

Nobel laureate Tom Cech wins 2017 Hazel Barnes Prize

March 27, 2017

University of Colorado Boulder Distinguished Professor Tom Cech, Colorado’s first Nobel Prize winner, has been named the 2017 Hazel Barnes Prize winner – the most distinguished award a faculty member can receive from the university.